In recent decades, scientific studies of chemical processes involving metabolites have been
steadily increasing, indicating that we are well into the metabolomics era. This has resulted in
numerous studies that explore the field of biomarkers. One of the medical areas most concerned with
these innovations is certainly that of childhood respiratory disorders, including asthma and cystic
fibrosis. This current study is a review of the literature about biomarkers used or studied in the field
of pediatric pulmonology, including asthma and cystic fibrosis.
Keywords: Asthma, biomarkers, children, cystic fibrosis, lungs, pediatric pulmonology.
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 2011; 184 602e615
James A, Konradsen J, Nordlund B. Serum YKL-40 is increased in children with bronchopulmonary dysplasia compared to children with asthma. Am J Respir Crit Care Med 2013; 187: A2536.
Rights & PermissionsPrintExport